UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non-Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update

Journal of clinical oncology, 2017-09, Vol.35 (25), p.2960-2974

2017

Volltextzugriff (PDF)

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

Journal of clinical oncology, 2015-10, Vol.33 (30), p.3488-3515

2015

Volltextzugriff (PDF)

American Society of Clinical Oncology Provisional Clinical Opinion: Epidermal Growth Factor Receptor (EGFR) Mutation Testing for Patients With Advanced Non–Small-Cell Lung Cancer Considering First-Line EGFR Tyrosine Kinase Inhibitor Therapy

Journal of clinical oncology, 2011-05, Vol.29 (15), p.2121-2127

2011

Volltextzugriff (PDF)

American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2009-12, Vol.27 (36), p.6251-6266

2009

Volltextzugriff (PDF)

Repetitive Transcranial Magnetic Stimulation for Generalized Anxiety Disorder: A Systematic Literature Review and Meta-Analysis

The international journal of neuropsychopharmacology, 2022-02, Vol.25 (2), p.144-146

2022

Volltextzugriff (PDF)

High-quality antidepressant prescribing: please consider whether "perfection is the enemy of progress"

BMC medicine, 2020-05, Vol.18 (1), p.150-150, Article 150

2020

Volltextzugriff (PDF)

2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2011-10, Vol.29 (28), p.3825-3831

2011

Volltextzugriff (PDF)

Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders

Frontiers in pharmacology, 2019-02, Vol.10, p.99-99

2019

Volltextzugriff (PDF)

Antidepressant-Induced Activation in Children and Adolescents: Risk, Recognition and Management

Current problems in pediatric and adolescent health care, 2018-02, Vol.48 (2), p.50-62

2018

Volltextzugriff (PDF)

Cancer Care Ontario and American Society of Clinical Oncology Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Stages I-IIIA Resectable Non–Small-Cell Lung Cancer Guideline

Journal of clinical oncology, 2007-12, Vol.25 (34), p.5506-5518

2007

Volltextzugriff (PDF)

American society of clinical oncology treatment of unresectable non-small-cell lung cancer guideline: Update 2003

Journal of clinical oncology, 2004-01, Vol.22 (2), p.330-353

2004

Volltextzugriff (PDF)

A Randomized, Placebo-Controlled Study of Duloxetine for the Treatment of Children and Adolescents With Generalized Anxiety Disorder

Journal of the American Academy of Child and Adolescent Psychiatry, 2015-04, Vol.54 (4), p.283-293

2015

Volltextzugriff (PDF)

Acute Neurofunctional Effects of Escitalopram in Pediatric Anxiety: A Double-Blind, Placebo-Controlled Trial

Journal of the American Academy of Child and Adolescent Psychiatry, 2021-10, Vol.60 (10), p.1309-1318

2021

Volltextzugriff (PDF)

Target to treatment: A charge to develop biomarkers of response and tolerability in child and adolescent psychiatry

Clinical and translational science, 2022-04, Vol.15 (4), p.816-823

2022

Volltextzugriff (PDF)

Pediatric Therapeutic Drug Monitoring for Selective Serotonin Reuptake Inhibitors

Frontiers in pharmacology, 2021-10, Vol.12, p.749692-749692

2021

Volltextzugriff (PDF)

Promoting the Emotional and Behavioral Success of Youths: A Practical Guide for Clinicians

1, 2022

Volltextzugriff (PDF)

The co-occurrence of cigarette smoking and bipolar disorder: phenomenology and treatment considerations

Bipolar disorders, 2011-08, Vol.13 (5-6), p.439-453

2011

Volltextzugriff (PDF)

1.4 Psychopharmacologic Treatment of Pediatric Anxiety Disorders

Journal of the American Academy of Child and Adolescent Psychiatry, 2016-10, Vol.55 (10), p.S85-S85

Strawn, Jeffrey R., MD

2016

Volltextzugriff (PDF)

Bipolar I disorder and major depressive disorder show similar brain activation during depression

Bipolar disorders, 2014-11, Vol.16 (7), p.703-712

2014

Volltextzugriff (PDF)

Selective Serotonin Reuptake Inhibitor Pharmacokinetics During Pregnancy: Clinical and Research Implications

Frontiers in pharmacology, 2022-02, Vol.13, p.833217-833217

2022

Volltextzugriff (PDF)

Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review

Expert opinion on pharmacotherapy, 2018-07, Vol.19 (10), p.1057-1070

2018

Volltextzugriff (PDF)

The Impact of Marijuana on Antidepressant Treatment in Adolescents: Clinical and Pharmacologic Considerations

Journal of personalized medicine, 2021-06, Vol.11 (7), p.615

2021

Volltextzugriff (PDF)

Treatment response biomarkers in anxiety disorders: From neuroimaging to neuronally-derived extracellular vesicles and beyond

Biomarkers in neuropsychiatry, 2020-12, Vol.3, p.100024, Article 100024

2020

Volltextzugriff (PDF)

Medication exposure and predictors of first mood episode in offspring of parents with bipolar disorder: a prospective study

Revista brasileira de psiquiatria, 2020-09, Vol.42 (5), p.481-488

2020

Volltextzugriff (PDF)

Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive Disorder: Design, Definitions, and Ongoing Challenges for Child and Adolescent Psychopharmacology Research

Journal of child and adolescent psychopharmacology, 2018-06, Vol.28 (5), p.363-363

2018

Volltextzugriff (PDF)

1 – 25 von 542

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(464)
Mit Volltextzugriff
(378)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non-Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

American Society of Clinical Oncology Provisional Clinical Opinion: Epidermal Growth Factor Receptor (EGFR) Mutation Testing for Patients With Advanced Non–Small-Cell Lung Cancer Considering First-Line EGFR Tyrosine Kinase Inhibitor Therapy

American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

Repetitive Transcranial Magnetic Stimulation for Generalized Anxiety Disorder: A Systematic Literature Review and Meta-Analysis

High-quality antidepressant prescribing: please consider whether "perfection is the enemy of progress"

2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders

Antidepressant-Induced Activation in Children and Adolescents: Risk, Recognition and Management

Cancer Care Ontario and American Society of Clinical Oncology Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Stages I-IIIA Resectable Non–Small-Cell Lung Cancer Guideline

American society of clinical oncology treatment of unresectable non-small-cell lung cancer guideline: Update 2003

A Randomized, Placebo-Controlled Study of Duloxetine for the Treatment of Children and Adolescents With Generalized Anxiety Disorder

Acute Neurofunctional Effects of Escitalopram in Pediatric Anxiety: A Double-Blind, Placebo-Controlled Trial

Target to treatment: A charge to develop biomarkers of response and tolerability in child and adolescent psychiatry

Pediatric Therapeutic Drug Monitoring for Selective Serotonin Reuptake Inhibitors

Promoting the Emotional and Behavioral Success of Youths: A Practical Guide for Clinicians

The co-occurrence of cigarette smoking and bipolar disorder: phenomenology and treatment considerations

1.4 Psychopharmacologic Treatment of Pediatric Anxiety Disorders

Bipolar I disorder and major depressive disorder show similar brain activation during depression

Selective Serotonin Reuptake Inhibitor Pharmacokinetics During Pregnancy: Clinical and Research Implications

Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review

The Impact of Marijuana on Antidepressant Treatment in Adolescents: Clinical and Pharmacologic Considerations

Treatment response biomarkers in anxiety disorders: From neuroimaging to neuronally-derived extracellular vesicles and beyond

Medication exposure and predictors of first mood episode in offspring of parents with bipolar disorder: a prospective study

Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive Disorder: Design, Definitions, and Ongoing Challenges for Child and Adolescent Psychopharmacology Research

Suchergebnisse filtern